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Abstract: Seaweeds—or marine macroalgae—notably brown seaweeds in the class 
Phaeophyceae, contain fucoidan. Fucoidan designates a group of certain fucose-containing 
sulfated polysaccharides (FCSPs) that have a backbone built of (1→3)-linked  
α-L-fucopyranosyl or of alternating (1→3)- and (1→4)-linked α-L-fucopyranosyl residues, 
but also include sulfated galactofucans with backbones built of (1→6)-β-D-galacto- and/or 
(1→2)-β-D-mannopyranosyl units with fucose or fuco-oligosaccharide branching, and/or 
glucuronic acid, xylose or glucose substitutions. These FCSPs offer several potentially 
beneficial bioactive functions for humans. The bioactive properties may vary depending on 
the source of seaweed, the compositional and structural traits, the content (charge density), 
distribution, and bonding of the sulfate substitutions, and the purity of the FCSP product. 
The preservation of the structural integrity of the FCSP molecules essentially depends on 
the extraction methodology which has a crucial, but partly overlooked, significance for 
obtaining the relevant structural features required for specific biological activities and for 
elucidating structure-function relations. The aim of this review is to provide information on 
the most recent developments in the chemistry of fucoidan/FCSPs emphasizing the 
significance of different extraction techniques for the structural composition and biological 
activity with particular focus on sulfate groups.  
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1. Introduction 
Fucoidan is a term used for a class of sulfated, fucose rich, polysaccharides found in the fibrillar 
cell walls and intercellular spaces of brown seaweeds of the class Phaeophyceae. These   
fucose-containing sulfated polysaccharides (FCSPs) principally consist of a backbone of (1→3)- and 
(1→4)-linked α-L-fucopyranose residues, that may be organized in stretches of (1→3)-α-fucan or of 
alternating α(1→3)- and α(1→4)-bonded L-fucopyranose residues. The L-fucopyranose residues may 
be substituted with sulfate (SO3
−) on the C-2 or C-4 (rarely on C-3), with single L-fucosyl residues 
and/or with short fucoside (fuco-oligosaccharide) side chains. If present, the fucoside side chains are 
usually O-4 linked to the α-L-fucopyranose backbone residues. However, as FCSPs structures of more 
brown seaweeds are being elucidated, as discussed further in the present review, it appears that FCSPs 
cover a broader range of complex polysaccharides than only those having fucan backbones. Apart from 
variations in the sulfate content and substitutions, also the monosaccharide composition of FCSPs 
varies among different species of brown seaweeds. Hence, in addition to fucose, different types of 
FCSPs may also contain galactose, mannose, xylose, glucose and/or glucuronic acid—usually in minor 
amounts [1].  
According to the ISI Web of Knowledge (Thomson Reuters) the number of published articles with 
the topic assigned as “fucoidan” has increased significantly since fucoidan, or “fucoidin” as it was first 
called, was first isolated from brown algae in 1913 [2]; in particular, a profound increase in the number 
of papers has taken place during the last 5–10 years. By now, the published papers related to fucoidan 
hit approximately 1800 (August 2011, Figure 1). The recent interest has mainly focused on the 
potentially beneficial biological activities of fucoidan and FCSPs in humans including antitumor, 
immunomodulatory, anti-inflammatory, antiviral, antithrombotic, anticoagulant, and antioxidant 
effects as well as specific activities against kidney, liver and urinary system disorders. 
While the development of research efforts involving FCSPs and their potential applications are 
advancing, the understanding of the mechanisms and the particular structural features of the FCSPs 
being responsible for the various biological activities is still incomplete. Seaweeds, including various 
brown seaweeds such as Undaria and Laminaria spp., are part of the food culture in Asia, notably in 
Japan, the Philippines, and Korea, and seaweed extracts have also been used as a remedy in traditional 
medicine. However, no standardized FCSPs extraction or purification protocols exist, and no specific 
pharmaceutical, dermatological, or nutraceutical applications have as yet been officially approved for 
these polysaccharides or their lower molar mass oligosaccharide derivatives.  
It is our proposition that more focus should be directed to the extraction and purification processes 
in order to obtain consistent protocols that account for the biodiversity of FCSPs from different 
seaweeds and to retain the structural features of significance for the specific bioactivity properties of 
FCSPs. The development and use of such consistent extraction procedures would also help in 
achieving a better understanding of structure-function relationships of FCSPs. The aim of this review 
is to bring attention to the detailed structural features of FCSPs in relation to their marine algal sources Mar. Drugs 2011, 9  
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and the extraction methodology, and to highlight recent knowledge concerning the structural 
determinants for FCSPs bioactivity.  
Figure 1. The trend during three decades of research on fucoidan as depicted by the 
number of published articles (Thomson Reuters, ISI Web of Knowledge). The number of 
articles was obtained according to topics being assigned in the ISI Web of Knowledge 
search engine with the following topic search terms: Fucoidan; Fucoidan*Algae; 
Fucoidan*Algae*Activity. 
 
2. Historic Overview: FCSPs Extraction Procedures and Chemical Analyses 
Extraction using dilute acetic acid followed by purification was used by Kylin already in 1913 to 
isolate “fucoidin”, subsequently referred to as fucoidan, from various species of Laminaria and   
Fucus [2]. Already in this first seminal report, Kylin reported that fucoidan extracted in this way 
mainly contained fucose, but also observed that the fucose occurred together with mannitol, alginic 
acid and laminarin [2] (Table 1); we now know that this interpretation was a result of co-extraction of 
these latter contaminants with the fucoidan. Two years later, Kylin reported that fucoidan isolated from 
Laminaria digitata contained methylpentose, interpreted as L-fucose, as well as some other   
pentoses [3]. A parallel report was published that same year by Hoagland and Lieb (1915) [4] who 
isolated a water-soluble polysaccharide from Macrocystis pyrifera that was closely related to if not 
identical with “fucoidan”, and shown to contain L-fucose as well as relatively high levels of calcium 
and sulfate. They employed a Na2CO3 soaking step and addition of hydrochloric acid which is why 
they also—if not mainly—isolated alginic acid (or alginate) during the extraction (Table 1). The 
rationale behind the extraction of alginate from the seaweed with Na2CO3 soaking is to convert all the 
alginate salts, typically calcium and magnesium alginate, to the sodium salt. Please note that the 
terminology used is confusing; alginic acid or alginate does not designate one particular 
monosaccharide or one type of homo-polysaccharide. With the advances in chemical analyses it is now 
known that alginic acid or alginate is comprised of guluronic and mannuronic acids; which are C-5 
epimers. Structurally, alginic acid, or alginate, is a linear hydrocolloid polymer that consists of blocks 
of (1→4) linked β-D-mannuronate and α-L-guluronate residues. The detailed structure of alginate may 
have mannuronate and guluronate in homopolymeric blocks of consecutive mannuronate residues   Mar. Drugs 2011, 9  
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(M-blocks), in consecutive guluronate residues (G-blocks), or in structural units of alternating 
mannuronate and α-L-guluronate residues (MG-blocks). Both mannuronic acid and α-L-guluronic acids 
are uronic acids, and they have in the past been analytically determined as uronic acids. However, 
uronic acids also include several other structures, e.g., glucuronic and galacturonic acids. In this 
review, we will address the significance of the compositional and structural differences, but also 
attempt to introduce a consistent terminology by grouping these compounds as uronic acids, especially 
as homopolymers do not belong to the group of FCSPs. Hoagland and Lieb (1915) [4] did not compare 
their extraction with Na2CO3 soaking to one without, but their report is nevertheless the first example 
of how the extraction procedure may influence the purity and, in turn, the analyzed composition of the 
extracted FCSPs (see Table 1). 
Table 1. Historic view of very early work, from 1913–1950, of fucoidan or FCSPs extraction 
and their reported composition from different brown seaweed species. 
The early FCSPs extraction procedures were based on using a dilute acid treatment, with either acetic 
or hydrochloric acid used as a first “extraction” step with the purpose of hydrolyzing the non-FCSP 
polysaccharides (Table 1). However, the extraction and purification methodologies employed in 
Year  Brown seaweed sp.  Reported FCSPs composition Extraction  method  References 
1913  Laminaria and Fucus 
Fucoidan contains fucose, that 
occurs together with mannitol, 
alginate and laminaran 
Dilute acetic acid extraction  Kylin, 1913 [2] 
1915  Laminaria digitata 
Fucoidan contains L-fucose and 
other pentoses 
Dilute acetic acid extraction  Kylin, 1915 [3] 
1915  Macrocystis pyrifera 
Mainly alginic acid, with some 
fucose-sulfate 
Soaking in 2% Na2CO3 for 24 h, 
filtration, HCl addition, recovery 
of precipitate by filtration, 
redissolution in 2% Na2CO3 
Hoagland and 
Lieb, 1915 [4] 
1931  Laminaria digitata 
Substantial amounts of calcium 
sulfate and uronic acid 
Soaking of the seaweed in water, 
precipitation of crude, sulfated 
polysaccharides by ethanol 
Bird and Haas, 
1931 [5] 
1931  Macrocystis pyrifera 
Methylpentose monosulphate 
polymer with fucose and 
alginate contaminants 
Repeated extraction with 2% HCl 
at room temperature for 48 h, 
precipitated with 90% ethanol 
Nelson and 
Cretcher,  
1931 [6] 
1937  Laminaria digitata 
Proposed (R-R′-O-SO2-OM)n 
with R = fucose, R′ as unknown, 
M being Na, K, Ca0.5, or Mg0.5 
Precipitation of droplets exuded 
from seaweed in boiling ethanol 
Lunde et al., 
1937 [7] 
1950 
Fucus vesiculosus, 
Fucus spirales, 
Himanthalia lorea, 
Laminaria clustoni 
Substantial amounts of fucose 
and sulfate; small amounts of 
uronic acid, galactose and 
xylose; metals and ash were also 
detected, ash was mainly 
calcium sulfate 
Aqueous extraction at ∼100 °C for 
24 h, extract treated with lead 
acetate (to precipitate alginate and 
proteins), filtrate solution treated 
with Ba(OH)2 to precipitate a 
“hydroxide-fucoidin complex” 
Percival and 
Ross, 1950 [8] 
1952  Fucus vesiculosus  Fucose, ash, sulfate 
0.1 M HCl at pH 2–2.5 and 70 °C 
for 1 h, 3-times, fractional 
precipitation with ethanol 
Black et. al., 
1952 [9] Mar. Drugs 2011, 9  
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different studies to isolate fucoidan/FCSPs from brown seaweed biomass have been modified to 
different extents since the first reports from 1913 and 1915. Bird and Haas (1931) [5], for example, 
used soaking of the brown alga biomass in water and precipitation of crude sulfate from the extract 
with ethanol to obtain fucoidan from L. digitata (Table 1). The product of this extraction was also 
found to contain relatively high levels of ash. The high ash levels were presumably chiefly a result of 
the presence of calcium sulfate in the algal polysaccharides. For the compositional analysis, acid 
hydrolysis using H2SO4 was typically used. This acid hydrolysis step might by itself have contributed a 
substantial amount of sulfate. As a consequence, the use of H2SO4 clearly biased the interpretation of 
the compositional analysis. Hence, the fucoidan isolated by Bird and Haas (1931) [5] was designated 
as carbohydrate sulfate (i.e., containing esterified sulfate) since the total sulfate content was approximately 
the double of that found in the ash. Uronic acid was also present in the FCSPs preparation extracted 
from L. digitata [5] (Table 1).  
Nelson and Cretcher (1931) [6] extracted fucoidan from Macrocystis pyrifera by repeated, extended 
(48 h) extraction with dilute HCl followed by isolation of the FCSPs by ethanol precipitation, and 
revealed the presence of sulfate in the form of ester groups in the precipitated product. They also 
confirmed that fucose was the only sugar identified in the unhydrolyzed residue after acid hydrolysis, 
even though their product contained uronic acid, considered to be due to alginate contamination 
(Table 1). Later, Lunde et al. [7] prepared fucoidan by directly precipitating the droplets exuded from 
freshly gathered L. digitata fronds in ethanol (Table 1). After purification via precipitation of the 
product from boiling ethanol they obtained a FCSPs specimen that contained 33–37% methylpentose 
(interpreted correctly as fucose), and 26–30% ash in which the sulfate content was 17–19%, which 
made up approximately half of the total sulfate estimated in the polysaccharide (35–38%). They 
proposed a structural unit formula, (R-R′-O-SO2-OM)n, for fucoidan and suggested that R was fucose 
or another pentose sugar residue, R′ was unknown, and M was Na
+, K
+, (½)Ca
2+ or (½)Mg
2+ [7] 
(Table 1). 
“In an attempt to reconcile some of the conflicting views on the nature of fucoidin” crude fucoidan 
extracts from F. vesiculosus, F. spirales, Himanthalia lorea and Laminaria clustoni were prepared by 
Percival and Ross (1950) [8]. Their methodology involved boiling of the seaweed biomass in neat 
boiling water for 24 h (hydrolysis treatment) followed by removal of alginates and protein by addition 
of lead acetate, then, after addition of barium hydroxide (presumably to precipitate alginate) the 
fucoidan was isolated as a crude lead hydroxide complex (Table 1). In order to isolate lead free 
fucoidan, the lead hydroxide complex was treated with dilute H2SO4 and fucoidan was then isolated 
after prolonged dialysis and filtration. The purest fucoidan specimen obtained was from H. lorea. This 
fucoidan isolated from H. lorea contained substantial amounts of fucose and sulfate; as well as small 
quantities of uronic acid, galactose and xylose. Metals and ash were also detected, and the ash was 
mainly made up of calcium sulfate [8]. Based on the data obtained the authors believed that the 
principal constituent of fucoidan was a polyfucose with one sulfate substitution on each fucose residue 
and that other constituents arose from adventitious impurities. A parallel paper was published in which 
it was proposed that the core structure of fucoidan from F. vesiculosus was built of 1→2 linked   
L-fucopyranose units, each carrying a sulfate group on C-4 [10]. As discussed later, the interpretation 
that the fucosyl units in the fucoidan were 1→2 linked turned out to be incorrect, as more advanced Mar. Drugs 2011, 9  
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analyses have now verified that the backbone of fucoidan from F. vesiculosus consists of alternating 
α(1→3) and α(1→4) linkages [11]. 
In the pursuit to obtain extensive quantities, a laboratory-scale extraction of fucoidan was reported 
by Black et al. [9]. Interestingly, the extracted product was referred to as a “polyfucose ethereal 
sulphate occurring in the Phaeophyceae”. Their optimal fucoidan extraction procedure was as follows: 
One part by weight of dried ground seaweed and 10 parts by volume of 0.1 M hydrochloric acid at 
pH  2.0–2.5 contacted at 70 °C with constant stirring for 1 h. A single acid hydrolysis extraction 
treatment using this method recovered about 50% by weight (w/w) of the theoretical maximum of 
fucoidan (recovered yield measured as % fucose obtained as % of total fucose in the seaweed dry 
weight), whereas three rounds of the acid extraction recovered more than 80% of the fucose present; 
the triple acid hydrolysis treatment (0.1 M HCl, pH 2.0–2.5, 70 °C, 1 h × 3) was therefore selected as 
the optimal extraction method (Table 1). After the acid hydrolysis treatment the crude fucoidan was 
isolated by fractional precipitation with alcohol and further purified by precipitation after addition of 
formaldehyde [9]. By this procedure samples of crude fucoidan containing 30–36% fucose were 
obtained; for example, the fucoidan recovered from F. vesiculosus using the optimal extraction 
protocol was analyzed to contain (by weight) 44% fucose; 26% total sulfate, and 31% ash [9].   
In terms of yields, calculated as fucose as % of total fucose, the results obtained for the four different 
algal species were: Pelvetia canaliculata 76%; F. vesiculosus 62%; Ascophyllum nodusum 54%, and  
L. cloustoni 20% [9]. The authors suggested that a more efficient extraction methodology,  
i.e., extracting higher fucose yields, could be achieved by increasing the water/seaweed ratio, 
extraction time or number of extractions. 
In a study about 20 years later, FCSPs from the brown seaweeds Himanthalia lorea, Bifurcaria 
bifurcata and Padina pavonia were extracted successively using dilute acid, followed by alkaline or 
neat water extraction, acid, and alkali in sequence [12] (Table 2). Prior to extraction, the seaweed 
fronds were treated with formaldehyde to polymerize phenolic constituents which might otherwise 
contaminate the extracted saccharides [12]. This extraction protocol produced a complex mixture of 
glucans, fucose-containing polysaccharides, and alginic acid which could be separated by fractional 
precipitation with ethanol, calcium salts (CaCl2) or by fractionation on resin columns. The FCSPs 
extracted in this fashion were reported to be heteropolysaccharides containing different levels of 
fucose, glucuronic acid, xylose, and esterified sulfate, together with traces of galactose [12]. The 
results also showed that the sulfate and uronic acid contents in the FCSPs separated from the aqueous 
calcium chloride and acid extracts varied significantly according to the seaweed species [12]. 
Another study was conducted on the purification of a sulfated heteropolysaccharide substance from 
Sargassum linifolium to elucidate its structural components [13]. The extraction was done using 
hydrochloric acid at pH 1.0 for 3 h at 80 °C (Table 2); the extract was then neutralized with aqueous 
sodium carbonate and precipitated with ethanol [13]. The resulting sulfated polysaccharide material, 
termed “sargassan”, was proposed to be built of glucuronic acid, mannose, and galactose residues with 
partially sulfated side-chains composed of galactose, xylose and fucose residues [13]. As discussed 
later, we now know that Sargassum spp. do indeed contain highly complex FCSPs structures built 
from this array of monosaccharides.  Mar. Drugs 2011, 9  
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Table 2. Extraction methods and reported chemical composition of different brown seaweed 
species and their corresponding order.  
Species Order  Extraction  method  Composition Reference 
Cladosiphon 
okamuranus 
Chordariales 
Seaweed-H2O suspension was treated 
with 30% HCl (pH 3) at 100 °C for  
15 min. Supernatant was neutralized 
with NaOH, precipitated with CaCl2 and 
EtOH for 20 h at 4 °C, precipitate was 
dissolved with H2O then dried 
fucose, glucose, uronic 
acid and sulfate 
Nagaoka et al., 
1999 [14] 
Adenocystis 
utricularis 
Ectocapales 
80% EtOH, 24 h, 70 °C pretreatment 
then extracted with water (or 2% CaCl2; 
or HCl) for 7 h at rt, followed by 
exhaustive extraction at 70 °C 
fucose, rhamnose, 
glucose, galactose, 
xylose, mannose, uronic 
acid and sulfate 
Ponce et al.,  
2003 [15] 
Himanthalia  
lorea 
Fucales 
Acid + alkali + water-acid-alkali 
sequence in 70 °C, 4 h. 
fucose, xylose, uronic 
acid, sulfate 
Mian and 
Percival,  
1973 [12] 
Ascophyllum 
nodosum 
Fucales 
Extracted at rt and then 70 °C with 
0.01 NaCl containing 1% CaCl 
fucose, xylose, 
galactose, glucose, 
sulfate 
Marais and 
Joseleau,  
2001 [16] 
Fucales 
Extracted with hot water and dilute 
alkali, formaldehyde treatment, then 
extracted with ammonium oxalate-oxalic 
acid for 6 h at 80 °C 
fucose, xylose, uronic 
acid sulfate 
Percival,  
1968 [17] 
Sargassum 
stenophyllum 
Fucales 
Extracted with water 7% w/v mL,  
12 h, 3×. Precipitated with EtOH and 
CaCl2 and cetylpyridinium chloride. 
Soluble fraction (SF) was then 
fractionated (F1–F6) 
fucose, xylose, 
mannose, galactose, 
glucose, sulfate and 
uronic acid 
Duarte et al., 
2001 [18] 
Sargassum sp. Fucales 
Extracted with 0.03 M HCl at 90 °C for 
4 h, single-step 
Fucose, rhamnose, 
galactose, glucose, 
mannose, xylose, uronic 
acid, sulfate 
Ale et al.,  
2011 [19] 
Sargassum  
linifolium 
Fucales 
Extracted with water at pH 1 (HCl), for 
3 h at 80 °C 
mannose, galactose, 
xylose, uronic acid and 
fucose residues 
Abel-fattah et al., 
1974 [13] 
Fucus evanescens; 
Fucus distichus 
Fucales 
Pretreatment: MeOH–CHCl3–H2O 
(4:2:1), then extracted 2% CaCl2 for  
5 h at 85 °C, precipitated and the 
precipitate was washed with water, 
stirred with 20% ethanolic solution and 
dissolved with water [20] 
fucose, xylose, 
galactose, uronic acid 
and sulfate 
Cumashi et al., 
2007 [21] 
Fucus serratus  Fucales 
Pretreatment: MeOH–CHCl3–H2O 
(4:2:1), then extracted 2% CaCl2 for 5 h 
at 85 °C, the extracts were collected by 
centrifugation, combined, dialyzed and 
lyophilized [22] 
fucose, xylose, 
mannose, glucose, 
galactose, uronic acid 
and sulfate 
Cumashi et al., 
2007 [21] Mar. Drugs 2011, 9  
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Table 2. Cont. 
Hizikia fusiforme  Fucales 
Powdered seaweed was extracted 
with H2O (1:10), 3×, 2 h at 70 °C, 
precipitated with EtOH and CaCl2 
then dried 
fucose, mannose, 
galactose, xylose, 
glucose, rhamnose, 
arabinose, uronic 
acid and sulfate 
Li et al.,  
2006 [23] 
Laminaria saccharina; 
Laminaria digitata; 
F. vesiculosus; 
F. spiralis  
Ascophyllum nodosum 
Laminariales 
and Fucales 
Extracted with 2% CaCl2 for 5 h at 
85 °C, precipitated with Cetavlon, 
transformation of Cetavlonic salts 
into calcium salts, and an alkaline 
treatment to remove acetyl groups 
and to transform fucoidan into 
sodium salts [24] 
fucose, xylose, 
mannose, glucose, 
galactose, uronic 
acid and sulfate 
Cumashi et al., 
2007 [21] 
Chorda filum  Laminariales 
Extracted with CHCl3–MeOH–H2O 
(2:4:1) followed by 80% EtOH, 
then extracted successively with 
2% CaCl2 at 20 and 70 °C, then 
with HCl (pH 2) and 3% Na2CO3, 
precipitated with calcium salt 
fucose, xylose, 
mannose, glucose, 
galactose, uronic 
acid and sulfate 
Chizhov et al., 
1999 [25] 
Undaria pinnatifida  Laminariales 
Ground seaweed extracted twice at 
rt for 6 h with 1% H2SO4, 
neutralized with 10% NaOH and 
lyophilized 
fucose, mannose, 
xylose, rhamnose, 
galactose, glucose 
and sulfate 
Hemmingson et al., 
2006 [26] 
Laminaria religiosa  Laminariales 
Water extraction at boiling temp. 
for 4 h, fucoidan fraction was 
obtained by using 0.09 HCl at 4 °C 
for 2 h, then precipitated with 85% 
EtOH and dried 
fucose, xylose, 
mannose, glucose, 
rhamnose, uronic 
acid and sulfate 
Maruyama and 
Yamamoto  
1984 [27] 
These early reports show that, with a few exceptions, treatment with dilute acid at ambient or 
slightly elevated temperature has been a preferred first step in extraction protocols for isolating 
fucoidan or FCSPs from different types of brown seaweeds (Tables 1 and 2). The use of different 
acids—or no acid at all—as well as the differences in extraction time and temperature during the 
extraction and further purification treatments have generated diverse compositional results and 
structural suggestions for fucoidan or FCSPs (Tables 1 and 2). The early reports almost unequivocally 
found that fucoidan mainly contained fucose and sulfate; nevertheless, the chemical composition of the 
most highly purified, but still crude fucoidan specimen from Himanthalea lorea indicated that the 
fucoidan of this seaweed species contained fucose, galactose, xylose, uronic acids as well as   
sulfate [8,14]. In the more recent reports, a pretreatment of the seaweed biomass prior to the real 
extraction treatment has been found to be advantageous to eliminate low molecular components   
(e.g., phenols); as already mentioned above, an early study used formaldehyde pretreatment [12]. 
However, more recent reports show that the pretreatment typically involves the use of a mixture of 
methanol, chloroform and water [22]. Removal of protein has also been considered. This can be 
facilitated via the use of proteolytic enzymes [28] (or by lead acetate treatment, as used by Percival 
and Roos in 1950 [8]). Another useful purification procedure has involved transformation of alginate Mar. Drugs 2011, 9  
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in the residual biomass into insoluble calcium salts by treatment of the FCSPs specimen with aqueous 
calcium chloride [19,20]. 
In conclusion, the use of an array of different extraction and purification techniques appear to have 
contributed to the confusion that has prevailed about the nature and composition of fucoidan and 
FCSPs ever since fucoidan was first described by Kylin early in the 20th century [2]. As detailed in the 
following, we now know that the initial suggestions [29,30] that fucoidan was built of α(1→2) linked 
L-fucopyranosyl residues were wrong. Fucoidan is built of 1→3-linked  α-L-fucopyranosyls or of 
alternating 1→3- and 1→4-linked  α-L-fucopyranosyl residues that may be sulfate substituted.   
We also know,that “fucoidans” isolated from certain brown algae have completely different structures 
being composed of sulfated galactofucans with backbones of (1→6)-linked  β-D-galacto- and/or 
(1→2)-β-D-manno-pyranosyl units with (1→3) and/or (1→4)-α-L-fucooligosaccharide branching. The 
available data thus show that the term “fucoidan” has been used for several different chemical 
structures and vice versa that fucoidan is a term that covers a diverse family of fucose-containing 
sulfated polysaccharides (Table 1). It is therefore more correct to use the term fucose-containing 
sulfated polysaccharides (FCSPs) rather than fucoidan as a collective term for these polysaccharides. 
3. Taxonomic Comparison of Fucoidan or FCSPs Structure 
3.1. Fucales 
In 1993 a revised structure of the polysaccharide backbone of the main FCSP product from   
F. vesiculosus was presented as α(1→3) linked instead of as α(1→2) linked [31]; it was also reported 
that fucose was attached to the backbone fucan polymer to form branching points, typically one for 
every 2–3 fucose residues within the chain, still with sulfate groups at position C-4 on the fucose  
units [31]. However, detailed analysis of the methyl derivatives obtained from partially desulfated  
F. vesiculosus polysaccharides revealed the presence of 2,4-di-O-methylfucose as well as   
2,3-di-O-methylfucose which indicated the presence of both α(1→3) and α(1→4) linked fucose 
residues [32] (Figure 2). A similar structure was also determined for a FCSPs-derived oligosaccharide 
of about 8–14 monosaccharide units extracted from Ascophyllum nodosum (Fucales) [11] (Figure 2).  
More recently, several studies—using highly advanced analytical methods—have documented that 
fucoidan from brown seaweed in the order of Fucales such as F. evanescens and F. serratus do indeed 
contain large proportions of both α(1→3) and α(1→4) glycosidic bonds [20–22] (Figure 2). Structural 
analysis of a depolymerized low molecular weight fraction of fucoidan from F. evanescens by 
MALDI-TOF and tandem ESI mass spectrometry has moreover shown that this fraction contains 
oligosaccharides with and without sulfate substitutions and that it mainly consists of α(1→3)-linked 
fucose residues being esterified with sulfate at C-2 [33]. This more detailed analysis has also revealed 
the presence of minor components of mixed monosulfated fucooligosaccharides containing both   
2-O- and 4-O-sulfated (1→4) bonded xylose and galactose residues: Xyl-(1→4)-Fuc, Gal-(1→4)-Fuc, 
Gal-(1→4)-Gal-(1→4)-Fuc, Gal-(1→4)-Gal [24]. Glucuronic acid (GlcA) was also detected as being a 
part of the non-sulfated fucooligosaccharides: Fuc-(1→3)-GlcA, Fuc-(1→4)-Fuc-(1→3)-GlcA,  
Fuc-(1→3)-Fuc-(1→3)-GlcA respectively [33]. Mar. Drugs 2011, 9  
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Figure 2. Typical structure of fucoidan (FCSPs) obtained from some brown seaweed 
species in the order of Fucales. The L-fucopyranose backbone of the fucoidan (FCSPs) 
extracted from A. nodosum and F. vesiculosus is connected by alternating α(1→3) and 
α(1→4) linkages [11]; The FCSPs from F. evanescens have a similar backbone built up 
with sulfate substituted at the 2- and 4-position of the fucose residues [20] (only sulfate 
substitutions on C-2 of fucose are shown in the Figure). Acetate substitutions may also be 
found at the C-4-position of 3-linked fucose and at C3 of 4-linked fucose units [22] 
(acetate substitutions not shown in the figure). For F. serratus L. a possible fucoside side 
chain at C-4 is also shown. 
 
Brown seaweed species in the order of Fucales have also been reported to contain very complex 
FCSPs structures having fucose and galactose in comparable amounts; these structures are generally 
referred to as sulfated galactofucans and are predominantly found among Sargassum species [18,34,35]. 
These sulfated galactofucans are mainly built of (1→6)-β-D-galactose and/or (1→2)-β-D-mannose 
units with branching points formed by (1→3) and/or (1→4)-α-L-fucose, (1→4)-α-D-glucuronic acid, 
terminal β-D-xylose and sometimes (1→4)-α-D-glucose [18]. Early studies also reported the existence 
of fucoglucuronans having a backbone of glucuronic acid, mannose and galactose residues with side 
chains of neutral and partially sulfated residues of galactose, xylose and fucose; notably present in 
Sargassum linifolium [13]. More recently, the FCSPs of this type extracted from the brown seaweed 
Sargassum stenophyllum (Fucales) were grouped into two different types: type I was found to contain 
a relatively high percentage of α-D-glucuronic acid and relatively few sulfate groups, while type II 
contained relatively small amounts of α-D-glucuronic acid and a high percentage of sulfate [18]. The 
type I polysaccharides were composed of a linear backbone formed mainly by (1→6)-β-D-galactose 
and/or (1→2)-β-D-mannose with branching chains formed by (1→3) and/or (1→4)-α-L-fucose,  
(1→4)-α-D-glucuronic acid, while in the type II polysaccharides the backbone was mainly built of 
short galactan chains [18]. 
Corresponding structures were observed in FCSPs fractions from Hizikia fusiforme a.k.a. 
Sargassum fusiforme (Fucales). These structures were separated by ion exchange chromatography after 
the FCSPs had been obtained via hot aqueous extraction, followed by ethanol and CaCl2 precipitation 
(Table 2). These chromatographically purified fractions predominantly contained fucose, mannose, 
galactose, uronic acid and sulfate [23] (Figure 3). In accordance with the findings of Duarte et al. [18] Mar. Drugs 2011, 9  
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the structural analysis of one of the main fractions purified by ion exchange chromatography indicated 
that the sulfate groups might be found in any position on the galactose/mannose backbone or on the 
fucose units (Figure 3). The sulfate groups in the FCSPs in this fraction, which had been isolated after 
3 rounds of extraction in hot water (70 °C), then ethanol and CaCl2 precipitation prior to chromatography 
(Table 2), were mainly found at C-6 of [→2,3)-Man-(1→], at C-4 and C6 of [→2)-Man-(1→] and at 
C-3 of [→6)-Gal-(1→] [23]. On the fucose, the sulfate groups were substituted at C-2, C-3 or C-4, 
while some fucose residues had two sulfate groups [23]. The core of these S. fusiforme FCSPs was 
mainly composed of alternating units of [→2)-α-D-Man-(1→] and [→4)-β-D-GlcA-(1→], with a minor 
portion of [→4)-β-D-Gal-(1→] units, and the branching points were at C-3 of [→2)-Man-(1→],  
C-2 of [→4)-Gal-(1→] and C-2 of [→6)-Gal-(1→], respectively [23] (Figure 3). 
Figure 3. Suggested structures of the FCSPs (fucoidan) from H. fusiforme [23] also known 
as  Sargassum fusiforme (Fucales); sulfate substitutions not shown. The structures also 
represent typical FCSPs structures from other Sargassum spp. [18].  
 
3.2. Laminariales and Other Brown Seaweed 
Various structures of FCSPs from brown seaweeds of the order of Laminariales have also been 
reported [36]. The available data indicate that the FCSPs derived from this seaweed order contain 
small amounts of other monosaccharides besides fucose. Interestingly, polysaccharides containing 
significant amounts of fucose and galactose and which seem to be compositionally and structurally 
similar to the fucoidan from Fucales brown seaweeds appear to be prevalent [26,35]. Structural 
analysis was conducted on the FCSPs from the sporophyll Undaria pinnatifida (Laminariales) and it Mar. Drugs 2011, 9  
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was found that the FCSPs had a high fucose/galactose ratio, high uronic acid, and low sulfate content. 
The most abundant fucopyranosyl units were substituted at the 3-; 2,3-; or 2,3,4-positions whereas 
fucose residues with substitutions at the 3,4- or 4-positions were less abundant [26]. The 
galactopyranosyl units were predominantly substituted at the 3- or at both the 3,4-positions [26]. 
FCSPs isolated from Chorda filum (Laminariales) have been shown to consist of a   
poly-α(1→3)-fucopyranose backbone with a high degree of branching mainly as α(1→2)-linked single 
α-L-fucopyranosyl residues (Figure 4) [24,25]; the fucopyranosyl residues were found to be sulfated 
mainly at C-4 and sometimes at the C-2 position, whereas some of the α(1→3)-linked fucose residues 
were shown by NMR to be C-2 acetylated [25]. A similar structure has been reported by   
Usov et al. [24] for the FCSPs isolated from L. saccharina (Laminariales) which are mainly built of 
(1→3)-linked  α-L-fucopyranose with sulfation at C-4 and sometimes at the C-2 position or with 
possible α-L-fucopyranosyl at C-2 (Figure 4). This FCSPs structure has also been found to be present 
in the body wall layer of the sea cucumber Ludwigothurea grisea (a marine invertebrate). The FCSPs 
of the sea cucumber body wall are essentially built of an α-(1→3)-fucopyranose backbone [37]. NMR 
analysis has indicated that 2,4-di-sulfo-L-fucopyranose and unsubstituted fucopyranose are present in 
equal proportions, and that 2-mono-sulfo-L-fucopyranose is present in twice that proportion [33]. The 
FCSPs from Lessonia vadosa (Laminariales) have also been studied by NMR spectroscopy and the 
data indicate that the polysaccharides are mainly composed of α(1→3)-bonded fucopyranose residues 
sulfated mainly at position C-4 and partially at position C-2 [38]. 
Figure 4. Structural motifs of FCSPs (fucoidan) from some brown seaweed species of the 
order Laminariales and Chordariales. FCSPs of Chorda filum and Laminaria saccharina 
consist of a poly-α-(1→3)-fucopyranoside backbone with sulfate mainly at C-4 and sometimes 
at the C-2 position; some of the backbone fucose residues may be acetylated at C-2   
(not shown) [24,25]. Cladosiphon okamuranus derived FCSPs also consist of a backbone 
of α(1→3)-linked-L-fucopyranose residues with sulfate substitutions at C-4 and/or with 
α(1→2)-linked single α-L-fucopyranosyl substitutions and vicinal glucuronic acid substitutions. 
Some of the side chain fucose residues may be O-acetylated (not shown) [14].  
 
Other algal fucoidans whose structures contain the same α(1→3)-backbone of fucose residues have 
been found in Analipus japonicas (Ectocarpales), Adenocystis utricularis (Ectocarpales) and Mar. Drugs 2011, 9  
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Cladosiphon okamuranus (Chordariales) [14,15,39], but the FCSPs from these brown algae also 
appear to contain other monosaccharides than fucose (Table 2). The detailed structural elucidation of 
the FCSPs from C. okamuranus (Chordariales) confirmed that this product was made up of a linear 
backbone of α(1→3)-fucopyranose units with a portion of the fucose residues carrying sulfate 
substitutions at C-4 but some of the fucose residues have also been found to be O-acetylated (Figure 4). 
The C. okamuranus FCSPs may also contain α-glucuronic acid substitutions at the C-2-positions of 
those backbone fucose residues that are not substituted by a sulfate group [14] (Figure 4).  
Methylation analysis, desulfation and NMR spectroscopy of the FCSPs fractions from Adenocystis 
utricularis (Ectocarpales) showed that these FCSPs contained the same α-(1→3)-fucopyranose 
backbone as that found in Chorda filum and Laminaria saccharina FCSPs, and that the fucopyranosyl 
units were mostly sulfated at C-4, and branched at C-2 with non-sulfated fucopyranosyl units; the 
galactan moiety, which was also present, was predominantly found to be a backbone structure of 
(1→3) and (1→6) D-galactopyranose units with sulfation mostly on C-4 [15]. Later, a similar structure 
was found in FCSPs extracted from Analipus japonicas (Ectocarpales) [39].  
The relatively large variations in the reported compositional and structural properties of the FCPSs 
extracted from different brown seaweed species thus clearly confirm the natural biodiversity of FCSPs 
notably as exemplified by the structures found in Fucales, e.g., in the Fucus sp. and Sargassum sp. 
(Figures 2 and 3). The (1→3)-linked α-L-fucopyranosyl backbone structure, with various extents of 
sulfate substitutions, is prevalent as the core backbone structure in the majority of the currently 
analyzed FCSPs. Nevertheless, the reported structural data for FCSPs from different brown seaweed 
species clearly indicate that there is no consistent basic structure of “fucoidan”. It also seems clear that 
FCSPs extracted from seaweeds under the same order have different composition, and in turn that the 
structural traits of FCSPs cannot be categorized or predicted according to algal order (Tables 1 and 2).  
When assessing the available compositional data the large variation in the composition of the FCSPs 
products obtained from different extraction methods is evident (Table 2). Recently, we optimized the 
extraction yields of FCSPs from Sargassum sp. by developing a single-step extraction procedure. 
While doing so, we also systematically examined the effects of different extraction parameters   
(i.e., acid concentration, time, and temperature) on the yields and composition of the FCSPs products 
obtained [19] (Table 2). All extraction factors affected the FCSPs yield. Lower total FCSPs yields, but 
higher fucose contents in the products were obtained with shorter extraction time [19]. The work also 
revealed that classical extraction treatment with HCl at elevated temperature and during extended time, 
i.e., a procedure similar to the one used by Black et al. [9], had a detrimental effect on the FCSPs yield 
as this treatment apparently disrupted the structural integrity of the fucose-containing polymer and 
caused degradation of the chains built of fucose residues [19]. Hence, some of the classic methods, 
employing relatively harsh acid treatments, may in fact have affected the composition and structure of 
the target FCSP products to different extents, and may have contributed to the prevailing “conflicting 
views on the nature of fucoidin” recognized already in 1950 by Percival and Ross [8]. A consensus to 
employ defined extraction protocols for extraction of FCSPs, or at least an agreement among scientists 
in the field to include a benchmark extraction procedure in their studies, would help to advance the 
understanding of these intriguing FCSPs substances.  Mar. Drugs 2011, 9  
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4. Bioactivity of Fucoidan or FCSPs 
In recent years, fucoidan or FCSPs from seaweed biomass have been the subject of many   
scientific studies aiming at assessing their potential biological activities including antitumor and 
immunomodulatory [40–42], antivirus [43], antithrombotic and anticoagulant [44], anti-inflammatory [45], 
and antioxidant effects [46], as well as their effects against various renal [47], hepatic [48] and uropathic 
disorders [49].  
Recently, low molecular weight FCSPs have been shown to have therapeutic potential in preventing 
intimal hyperplasia in both in vivo and in vitro studies: Contact with low molecular weight FCSPs 
(“fucoidan”) thus increased the migration of human vascular endothelial cells and induced decreased 
migration of vascular smooth muscle cells in vitro [50]. In an in vivo rat experiment FCSPs reduced 
the intimal hyperplasia in the rat aortic wall after balloon injury [50]. Furthermore, an in vivo efficacy 
study of fucoidan films conducted using a rat model showed that during cecal-sidewall surgery a 
fucoidan film wound healing treatment reduced the adhesion scores by approximately 90% and 
resulted in 50% to 100% of animals being adhesion free [51].  
In this review, the most significant bioactivities of FCSPs, including antitumor and 
immunomodulatory, anticoagulant and antithrombotic effects will be presented with special focus on 
the relationship between the FCSP structural features and biological activity.  
4.1. Antitumor and Immune-Response Activities 
Several different therapeutic strategies such as chemotherapy, radiation therapy, surgery or 
combinations hereof have been used to treat different types of cancer. Unfortunately, several of these 
treatments provide only minimal benefits; moreover, there are undesirable complications and long term 
side effects of the treatments [52,53]. Consequently the quest for potential preventive or therapeutic 
measures against cancer has been going on for years and recently the focus has been directed towards 
bioactive compounds of natural origin, including FCSPs from brown seaweeds [1]. Many reports have 
been published which indicate the antitumor and immune-response modulating activity of FCSPs in 
both in vivo and in vitro studies [40–42,54,55]. 
Sulfated polysaccharide fractions from Sargassum fulvellum,  S. kjellmanianum,  L. angustata,  
L. angustata var. longissima, L. japonica, Ecklonia cava, and Eisenia bicyclis have been evaluated for 
their bioactivities, and they have been found to exert remarkable growth inhibitory activities on 
Sarcoma-180 cells implanted into mice and to possess antitumor activity against L-1210 leukemia  
in mice [56–58]. Recently, we reported the potent in vitro bioactivity of FCSPs extracted from 
Sargassum  sp.  and  F. vesiculosus against lung and skin cancer cell growth [42]. The antitumor 
mechanism of FCSPs from sporophylls of Undaria pinnatifida has been described by   
Maruyama et al. [41,59]. The available findings indicate that antitumor activity of FCSPs may be 
associated with a significant enhancement of the cytolytic activity of natural killer (NK) cells augmented 
by increased production of macrophage-mediated immune response signaling molecules [59–61], 
namely interleukins (IL)-2, IFN-γ and IL-12 [42,59], and induction of apoptosis [42]. 
Macrophage activation by polysaccharides is mediated through specific membrane receptors. The 
major receptors reported for polysaccharides recognition in macrophages are glycoproteins including Mar. Drugs 2011, 9  
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Toll-like receptor-4 (TLR-4), cluster of differentiation 14 (CD14), competent receptor-3 (CR-3) and 
scavenging receptor (SR) [61]. Activation of these receptors is mediated by intracellular signaling 
pathways and the family of mitogen-activated protein kinases (MAPKs) plays a critical role notably in 
the production of nitric oxide (NO) which can lyse tumors [61]. MAPK family members such as p38 
MAPK, extracellular regulated kinase (EKR1/2) and stress-activated protein kinase/c-Jun-N-terminal 
kinase play an important role in the activation of macrophages by polysaccharides such as FCSPs [61,62] 
(Figure 5A). Activated MAPKs lead to activation of transcription factors resulting in induction of 
various genes [61]. Activation of macrophages induces the production of cytokines such as   
interleukin-12 (IL-12) which in turn stimulate the development of T-cells (Figure 5B). T-cells produce 
interleukin-2 (IL-2) that in turn activates NK cells proliferation. The NK cells themselves produce 
immunologically important cytokines, notably IFN-γ, which can further provoke the participation of 
macrophages in the stimulation of T-cell via induction of IL-12 [41,59] (Figure 5B).  
NK cells appear to represent a first line of defense against the metastatic spread of blood-borne 
tumor cells, and normal NK activity may be important in immune surveillance against tumors [63]. 
NK-mediated killing of target cells by apoptosis is facilitated by activation of caspase cascades   
(Figure 5B). In tumor bearing mice, FCSPs appear to act as an immunopotentiator leading to increased 
antitumor effectiveness as exhibited by increased immune response against A20 leukemia cells and a 
lowering of the tumor size in transgenic (DO-11-10-Tg) mice [41]. Moreover, recent investigations of 
the immunomodulatory activity of FCSPs in rats with aspirin-induced gastric mucosal damage suggest 
that the gastro-protective effect of fucoidan against aspirin-induced ulceration may take place through 
the prevention of elevation of pro-inflammatory cytokines, IL-6 and IL-12 [64]. 
Figure 5. Proposed mechanism responsible for fucoidan bioactivity: (A) Macrophage 
activation by FCSPs as mediated through specific membrane receptor activation   
namely TLR-4, CD14, CR-3 and SR which in turn induce intracellular signaling via   
mitogen-activated protein kinases (MAPKs); (B) Activation of macrophages lead to 
production of cytokines such as IL-12, IL-2 and IFN-γ which enhance NK cell activation 
that may stimulate T-cell activation further via IFN-γ. 
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Apoptosis is one of the most prevalent pathways through which FCSPs can inhibit the overall 
growth of cancer. Previous studies have shown that different types of FCSPs can induce apoptosis in 
melanoma cells [42], HT-29 colon cancer cells [65], MCF-7 human breast cancer cells [66], and   
HS-Sultan human lymphoma cells [62]. In human HS-Sultan cells, the apoptosis may occur via activation 
of caspase-3 [62]; and in MCF-7 cells via caspase-8 dependent pathways [66]. Alternatively, FCSPs 
induced apoptosis may take place through activation of caspases via both death receptor-mediated and 
mitochondria-mediated apoptotic pathways [65].  
4.2. Anticoagulant and Antithrombotic Activities 
The earliest published report describing the anticoagulant activity of fucoidan was published in 
1957 [67]. In that report it was shown that a certain fraction of fucoidan from F. vesiculosus possessed 
powerful anticoagulant activity that qualified fucoidan to belong to the group of heparinoids [67]. 
Heparin is a biomolecule containing highly sulfated glucosaminoglycan that is widely used as an 
injectable anticoagulant. It has been reported that the anticoagulant mechanisms of fucoidan are related 
to both antithrombin and heparin cofactor II-mediated activity [68,69], but the mechanisms by which 
fucoidan exerts anticoagulant activity remain controversial [32]. Hence, any possible relations between 
the physical and chemical properties, the structure, and the anticoagulant activity of fucoidan remain to 
be firmly established. The uncertainties are mainly due to the structural variation of fucoidan between 
algal species, but most likely also a result of the different extraction methodologies employed to isolate 
FCSPs that appear to have produced FCSPs of different composition, structure, and size, which have 
given rise to conflicting results in the detailed studies of mechanisms of anticoagulant activity [32,70].  
Results obtained using the so called activated partial thromboplastin time assay (APTT) have 
strongly indicated that FCSPs from F. vesiculosus have specific anticoagulant activity. Comparable 
results have been obtained in two independent studies using FCSPs dosages equivalent to 9–13 U/mg 
versus 167 U/mg for heparin; and 16 U/mg versus 193 U/mg heparin, respectively [71,72]. When 
FCSPs samples isolated from nine brown seaweed species were tested for anticoagulant activities, the 
APTT results were significant at 12–38 U/mg as compared to at 167 U/mg for heparin [73].   
A remarkable finding for anticoagulant action was also reported by Kitamura et al. [74], who showed 
that a FCSPs fraction from L. angustata var. longissima (Laminariales) had antithrombin activity at 
200 U/mg, equivalent to a dose of 140 U/mg heparin. The particular FCSPs fraction having 
anticoagulant activity had a molecular weight of ~21–23 kDa and contained fucose-galactose-sulfate at 
a ratio of 9:1:9 with the sulfate substitutions at C-4 of the fucose residues [74].  
It has been postulated that it is not a specific structural trait that determines fucoidan’s ability to 
elicit anticoagulant activity, but rather that the anticoagulant effect is due to a multitude of structural 
features including monosaccharide composition, molecular weight, sulfation level, and position of 
sulfate groups on the main chain of the polysaccharide [69,75–77]. The comprehensive study of the 
anticoagulant activity of fucoidan by Cumashi et al. [21] also noted that neither the content of fucose 
and sulfate nor other structural features affected the anticoagulant efficacy. FCSPs from C. okamuranus 
(Chordariales) have been reported to exert virtually no anticoagulant effect, and this could be due to 
the low amount of sulfate in its polymer backbone and/or the presence of vicinal branching points 
formed by 2-O-α-D-glucuronyl substituents (Figure 4) [21,14]. On the other hand, the concentrations Mar. Drugs 2011, 9  
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of C-2 sulfate and C-2,3-disulfated sugar residues (Figure 2) have been reported to be a common 
structural feature for fucoidan anticoagulant activity [11]. The anticoagulant activity of high molecular 
weight FCSPs from Ecklonia kurome were thus reported to be dependent on both molecular weight 
and sulfate content [76]: Higher molecular weight FCSPs (i.e., 27 and 58 kDa) showed higher 
anticoagulant activity than lower molecular weight FCSPs (i.e., ≤10 kDa); and FCSPs samples having 
a high molar ratio of sulfate to total sugar residues were found to exhibit inhibitory effects on 
fibrinogen clotting by thrombin reaction [76]. These results were supported by data reported by 
Haroun-Bouhedja et al. [78] who reported a relationship between the extent of sulfate group 
substitutions and the biological activities of fucoidan. The anticoagulant activity of low molecular 
weight (LMW) fucoidan, i.e., MW < 18 kDa was thus found to decrease with decreasing degree of 
sulfation, and very low-sulfate (<20%) or desulfated LMW fucoidan lost its anticoagulant activity, but 
retained some antiproliferative activity on CCL39 fibroblast cells [78]. In contrast, LMW fucoidan 
with sulfate content higher than 20% was found to exert profound anticoagulant activity as well as 
antiproliferative effects on fibroblast cell line CCL39 cells in a dose-dependent fashion [78].  
Some studies suggest that also the sugar composition (e.g., fucose, galactose, mannose, etc.) or the 
type of oligo- or polysaccharides of the FCSPs may play an important role for anticoagulant   
activity [75,79]. However, the series of investigations conducted by Pereira et al. [32,80,81] indicated 
that a 2-sulfated, 3-linked α-L-galactan, but not α-L-fucan, was the potent thrombin inhibitor mediated 
by anti-thrombin of heparin cofactor II. These findings have however also pointed out that it is not 
necessarily the sugar composition but rather the sulfate substitutions on the sugars that determine the 
anticoagulant activity of fucoidan—or both [82].  
Most of the reported studies were carried out with crude, diverse and complex FCSPs obtained via 
extraction from brown seaweeds as opposed to being chemically well defined structures. For this 
reason it is not easy to identify a structure versus activity relationship because of the presence of highly 
branched portions and the complex distributions of sulfate and acetyl groups in algal FCSPs. This 
aspect was attempted resolved by use of invertebrate polysaccharides [83]. The data obtained indicated 
that regular, linear sulfated α-L-fucans and sulfated α-L-galactans express anticoagulant activity, which 
is not simply a function of charge density, but critically dependent on the pattern of sulfation as well as 
monosaccharide composition. Sulfated α-L-fucans and fucosylated chondroitin sulfate were also shown 
to elicit antithrombotic activity when tested on in vivo models of venous and arterial thrombosis in 
experimental animals [83]. 
4.3. Bioactivities and Oversulfation of FCSPs  
In 1984 crude FCSPs fractions from Sargassum kjellmanianum were prepared in order to 
investigate the influence of the sulfation levels on the survival of L-1210 leukemia bearing mice; and 
on the growth of Sarcoma-180 cells [58]. The study showed that the fraction with the highest sulfation 
was the most effective against L-1210 leukemia bearing mice and it produced an increase in life span 
of 26%. On the other hand, this particular FCSPs fraction was also less effective in inhibiting growth 
of Sarcoma-180 cells subcutaneously implanted into mice [58].  
Since then, several investigations have focused on the effect of oversulfation of FCSPs on biological 
activity [54,78,84–89]. Oversulfated FCSPs may be obtained by further sulfation of native FCSP Mar. Drugs 2011, 9  
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molecules using dimethylformamide as solvent and a sulfur trioxide-trimethylamine complex as the 
sulfating agent [86]. The inhibitory effects of such oversulfated FCSPs were investigated on the 
invasion of Murine Lewis Lung Carcinoma cells through a reconstituted membrane basement 
fragment, socalled laminin [86]. Oversulfated FCSPs were found to be the most potent inhibitor of 
tumor cell invasion and were also, in particular, found to inhibit tumor cell adhesion to laminin better 
than native and desulfated FCSPs. The most potent oversulfated FCSP structures had sulfate groups on 
both the C-3 and C-4 positions of the fucose units; hence, the particular spatial orientation of the 
negative charges in the FCSPs molecules may also be an important determinant of bioactivity [86]. 
The study did not allow firm conclusions to be drawn with respect to mechanisms of action, but it was 
suggested that the increased negative charge resulting from oversulfation might promote the formation 
of FCSPs-protein complexes involved in cell proliferation, in turn suppressing cell growth [86].  
When the importance of the spatial orientation of the negative charges on the FCSPs was investigated 
in more depth it was confirmed that this feature plays a major role in determining the binding potency 
of FCSPs to vascular endothelial growth factor 165 (VEGF165) [88]. Both native and oversulfated 
FCSPs have been tested for their anti-angiogenic actions in vivo and for their in vitro anti-proliferative 
effects against B16 melanoma cells, Sarcoma-180 and Lewis lung carcinoma cells: The interaction of 
oversulfated FCSPs with VEGF165 occurred with high affinity and resulted in the formation of highly 
stable complexes, thereby interfering with the binding of VEGF165 to vascular endothelial growth 
factor receptor-2 (VEGFR-2). The results showed that both native and oversulfated FCSPs were able 
to suppress neovascularization in mice implanted Sarcoma-180 cells; and that both FCSPs types 
inhibited tumor growth through the prevention of tumor-induced angiogenesis, but the data indicated 
that sulfation tended to give more potent effects [88]. 
Native and oversulfated FCSPs derived from Cladosiphon okamuranus (Chordariales) were 
analyzed using 
1H NMR spectroscopy and it was suggested that whereas natural sulfation   
produced 4-mono-O-sulfo-L-fucopyranose the oversulfated FCSPs contained 2,4-di-, 2-mono-, and   
4-mono-O-sulfo-L-fucopyranose [89]. It was also suggested that sulfate content and the positioning of 
sulfate groups, e.g., 2,4-di- vs. 4-mono, might be important for the anti-proliferative activity of 
fucoidan in a human leukemia cell line (U937), an effect which is presumed to take place via induction 
of apoptosis associated with activation of caspase-3 and -7 [89].  
The effects of oversulfation of low and high molecular weight FCSPs derivatives from F. vesiculosus 
and heparin on lipopolysaccharide (LPS)-induced release of plasminogen activator inhibitor-1 (PAI-1) 
from cultured human umbilical vein endothelial cells (HUVEC) were examined by Soeda et al. [87]. 
Their study demonstrated that all oversulfated FCSPs derivatives including high molecular weight 
derivatives of 100–130 kDa were effective in suppressing the LPS-induced PAI-1 antigen, and 
supported an important role of the degree of sulfation for bioactivity [87].  
The correlation of oversulfation and conformation of molecular sizes of FCSPs for anticancer 
activity using human stomach cancer cell lines AGS was evaluated recently for FCSPs isolated from 
dried Undaria pinnatifada FCSPs [54]. The data showed that the oversulfated, low molecular weight 
FCSP derivatives increased the inhibition of cell growth, while the growth inhibition was less for 
native, high molecular weight FCSPs and for oversulfated high molecular weight FCSPs [54]. The 
differences were suggested to be a result of the smaller molecular weight fractions having a less Mar. Drugs 2011, 9  
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compact conformation than the higher, which may have allowed a higher extent of sulfate substitution 
to occur during oversulfation.  
5. Conclusions 
Fucoidan—or FCSPs—are an important group of polysaccharides that show remarkable biological 
actions notably anticoagulant, antitumor and immune-response activities. Despite intensive research, 
the exact correlation between the bioactivity and the structural molecular features of FCSPs—which 
vary depending on seaweed species and extraction methodology—has yet to be clarified.  
The preservation of the structural integrity of the FCSPs molecules nevertheless appears crucial for 
maintaining the biological properties and it has been clearly shown that the extraction treatment 
employed affects the composition and thus the structural features of the FCSPs substances.  
The diverse structures and varied chemical composition of FCSPs may have hindered the development 
of an in-depth understanding of the precise properties of significance for specific bioactivity effects.  
Important structural issues for bioactivity appear to include the degree of sulfation and the size of 
the FCSP molecules. Oversulfated FCSPs have thus been found to be potent inhibitors of tumor cell 
invasion compared to desulfated native FCSPs. Low molecular weight FCSPs have been shown to be 
effective in inhibiting human stomach cancer cell growth and to exert anticoagulant activity provided 
that the extent of the degree of sulfation was relatively high. Loss of anticoagulant activity has been 
observed with decreasing degree of sulfation, although anti-proliferative effects on fibroblast cell lines 
were retained.  
Undoubtedly, the presence of impurities influences the biological properties of FCSPs and therefore 
may currently hinder our full understanding of the biological activity of fucoidan or FCSPs. Hence the 
development of standard extraction procedures for FCSPs including hydrolysis treatment, purification 
and fractionation methodology, preferably with specific steps adapted to the particular botanical order 
of the seaweed, will generate a better, common basis for analysis and understanding of bioactivities 
and the mechanisms determining the bioactivities of FCSPs. On this basis it may even be possible to 
target specific structural features and in turn tune the extraction procedure to obtain specific 
bioactivities via the use of targeted extraction methodologies.  
Despite the availability of early, seminal studies of the extraction of FCSPs from brown seaweeds 
the understanding of the complex structures of FCSPs, is far from complete. 
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